Terms: = Head and neck cancer AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R AND Prognosis
3 results:
1. Cuproptosis/OXPHOS tendency prediction of prognosis and immune microenvironment of esophageal squamous cell carcinoma: Bioinformatics analysis and experimental validation.
Li L; Cheng H; Gong L; Huang Y; Yang J; Yan Q; Dai S; Wang J
Gene; 2024 Apr; 902():148156. PubMed ID: 38211899
[TBL] [Abstract] [Full Text] [Related]
2. Differentiated Thyroid cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract] [Full Text] [Related]
3. Fra-1 Regulates the Expression of hmga1, Which is Associated with a Poor prognosis in Human Esophageal Squamous Cell Carcinoma.
Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
[TBL] [Abstract] [Full Text] [Related]
